1. Home
  2. TIL vs ABVE Comparison

TIL vs ABVE Comparison

Compare TIL & ABVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TIL
  • ABVE
  • Stock Information
  • Founded
  • TIL 2018
  • ABVE 2019
  • Country
  • TIL United States
  • ABVE Canada
  • Employees
  • TIL N/A
  • ABVE N/A
  • Industry
  • TIL Biotechnology: Pharmaceutical Preparations
  • ABVE Packaged Foods
  • Sector
  • TIL Health Care
  • ABVE Consumer Staples
  • Exchange
  • TIL Nasdaq
  • ABVE Nasdaq
  • Market Cap
  • TIL 230.1M
  • ABVE 35.9M
  • IPO Year
  • TIL 2021
  • ABVE N/A
  • Fundamental
  • Price
  • TIL $24.49
  • ABVE $3.63
  • Analyst Decision
  • TIL Buy
  • ABVE
  • Analyst Count
  • TIL 5
  • ABVE 0
  • Target Price
  • TIL $119.00
  • ABVE N/A
  • AVG Volume (30 Days)
  • TIL 310.3K
  • ABVE 34.9M
  • Earning Date
  • TIL 08-12-2025
  • ABVE 02-15-2025
  • Dividend Yield
  • TIL N/A
  • ABVE N/A
  • EPS Growth
  • TIL N/A
  • ABVE N/A
  • EPS
  • TIL N/A
  • ABVE N/A
  • Revenue
  • TIL N/A
  • ABVE $213,446,206.00
  • Revenue This Year
  • TIL N/A
  • ABVE N/A
  • Revenue Next Year
  • TIL N/A
  • ABVE N/A
  • P/E Ratio
  • TIL N/A
  • ABVE N/A
  • Revenue Growth
  • TIL N/A
  • ABVE N/A
  • 52 Week Low
  • TIL $9.70
  • ABVE $0.25
  • 52 Week High
  • TIL $92.00
  • ABVE $4.40
  • Technical
  • Relative Strength Index (RSI)
  • TIL 47.69
  • ABVE N/A
  • Support Level
  • TIL $21.80
  • ABVE N/A
  • Resistance Level
  • TIL $26.91
  • ABVE N/A
  • Average True Range (ATR)
  • TIL 3.52
  • ABVE 0.00
  • MACD
  • TIL -0.37
  • ABVE 0.00
  • Stochastic Oscillator
  • TIL 35.14
  • ABVE 0.00

About TIL Instil Bio Inc.

Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.

About ABVE Above Food Ingredients Inc. Common Stock

Above Food Ingredients Inc is a differentiated, regenerative ingredient company. Its products are made with real nutritious, flavorful ingredients and delivered with transparency. Its vision is to create a healthier world one seed, one field, and one bite at a time. With a robust chain of custody of plant proteins, enabled by scaled operations and infrastructure in primary agriculture and processing, and proprietary seed development capabilities that leverage the power of artificial intelligence driven genomics. The company delivers nutritious foods to businesses and consumers with traceability and sustainability. Above Food's consumer products and brands are available in grocers across Canada and the United States.

Share on Social Networks: